Skip to main content
PLOS Genetics logoLink to PLOS Genetics
. 2021 May 25;17(5):e1009563. doi: 10.1371/journal.pgen.1009563

The Exon Junction Complex and intron removal prevent re-splicing of mRNA

Brian Joseph 1,2, Eric C Lai 1,2,*
Editor: Teresa Bowman3
PMCID: PMC8184009  PMID: 34033644

Abstract

Accurate splice site selection is critical for fruitful gene expression. Recently, the mammalian EJC was shown to repress competing, cryptic, splice sites (SS). However, the evolutionary generality of this remains unclear. Here, we demonstrate the Drosophila EJC suppresses hundreds of functional cryptic SS, even though most bear weak splicing motifs and are seemingly incompetent. Mechanistically, the EJC directly conceals cryptic splicing elements by virtue of its position-specific recruitment, preventing aberrant SS definition. Unexpectedly, we discover the EJC inhibits scores of regenerated 5’ and 3’ recursive SS on segments that have already undergone splicing, and that loss of EJC regulation triggers faulty resplicing of mRNA. An important corollary is that certain intronless cDNA constructs yield unanticipated, truncated transcripts generated by resplicing. We conclude the EJC has conserved roles to defend transcriptome fidelity by (1) repressing illegitimate splice sites on pre-mRNAs, and (2) preventing inadvertent activation of such sites on spliced segments.

Author summary

The Exon Junction Complex (EJC) is a conserved multiprotein complex that is deposited ~20–24 nucleotides upstream of exon-exon junctions during mRNA splicing. Although the EJC is well-conserved, many of its overt regulatory requirements differ between species. For example, the mammalian EJC is involved in mRNA surveillance and nonsense mediated decay (NMD), and also suppresses cryptic splicing. On the other hand, the Drosophila EJC does not mediate NMD, and it has multiple roles in promoting splicing of long introns and suboptimal splicing substrates. Here, we unify this by showing that the Drosophila EJC suppresses splicing at hundreds of illegitimate cryptic splice sites, which are presently unannotated in the well-studied Drosophila genome. As in mammals, this role takes advantage of the sequence-independent deposition of the EJC upstream of splice sites, and appears to represent an ancestral function. We expand this concept by showing the necessity of the EJC to prevent resplicing in exonic remnants that inherently regenerate splice sites following canonical splicing. Importantly, cDNA expression constructs evade EJC regulation, and we show that utilization of cDNAs can unintentionally trigger re-splicing into unanticipated products with internal deletions.

Introduction

Canonical splice sites contain instructive information across the exon/intron boundary. Pioneering studies using genetics and biochemistry demonstrated that U1 snRNA establishes contacts with 5’ SS, AG|GUAAGU (where | marks the exon/intron boundary) [14]. Similarly, the U2AF complex shows preference for a AG|GU motifs at 3’ SS, which includes two nucleotides into the exon [5]. Moreover, exonic segments of splice sequences are also utilized during the catalytic stages of splicing, for example the juxtaposition of exon boundaries by U5 snRNA [6,7]. Thus, when processed, exon junctions contain remnants of splice sequences. However, the activity of these segments post-splicing remains little explored.

It has been observed that exon junction sequences can function as cryptic splice sites [8,9]. This has led to one view of intron birth, in which they insert into cryptic or protosplice sites; sequences that are typically inactive but contain the information content required to pair with spliceosomal building blocks, such as U1 snRNP or U2AF [2,5]. However, an alternate assessment is that intron removal may regenerate cryptic splice sites. This has been observed at cassette exons in the context of recursive splicing, but the recent discovery of suppressed, 5’ recursive splice sites at constitutive exon junctions [10,11] reignites this discussion by suggesting that even seemingly constitutive exons may regenerate cryptic splice sites at exon junctions. Furthermore, these studies showed that recruitment of the Exon Junction Complex (EJC) silences the activity of cryptic splice sites [10,11].

The EJC is a multisubunit conglomerate that is deposited in a sequence-independent fashion ~24 nt upstream of exon-exon junctions [12,13]. Assembly of its three-member core complex begins during splicing, and the first step involves the position-specific deposition of the DEAD-box protein eIF4AIII onto RNA by the spliceosome factor CWC22. Next, a heterodimer of MAGOH/Mago Nashi and RBM8A/Y14/Tsunagi binds eIF4AIII, stabilizing the complex on RNA. The core EJC complex interacts with multiple peripheral complexes involved in diverse RNA metabolism pathways [14]. Accordingly, EJC dysfunction broadly affects development, disease and cancer [15].

Curiously, while the EJC is well-conserved, the literature indicates fundamental differences in its requirements between invertebrates and vertebrates [14]. The EJC was first linked to the process of nonsense mediated mRNA decay [16,17], a process that exploits deposition of the EJC by the spliceosome [18]. Translation removes EJCs from the open reading frame, but the presence of premature termination codons cause EJCs to remain within aberrant 3’ UTRs, thereby triggering NMD. However, as introns do not inherently elicit NMD in Drosophila, its pathway does not appear to involve the EJC [19].

Physical associations between the EJC and the spliceosome [20] have also warranted attention towards splicing-related functions of the EJC. Here, as well, there is evidence for functional distinctions amongst species. In Drosophila, the EJC positively regulates splicing of long introns, such as mapk [21,22], and also activates suboptimal splice sites, such as within piwi [23,24]. By contrast, recent analysis of the mammalian EJC shows that many of its direct splicing targets are instead inhibited [10,11], indicating a role in cryptic splice site avoidance during pre-mRNA maturation. However, the generality and scope of such a mode of splicing control has not been addressed. Overall, the available data suggest divergent impacts of the EJC on splicing, either promoting (in Drosophila), or inhibiting (in mammals) this fundamental mRNA processing process.

Here, we analyze the effects of the EJC on splicing in flies in detail. Although Drosophila melanogaster has one of the best annotated metazoan transcriptomes [2527], we unexpectedly detect many hundreds of novel splice junctions upon depletion of core EJC components in a single celltype. De novo splicing analysis demonstrates the fly EJC protects neighboring introns from cryptic splice site activation, as in mammals This function is required under unusual circumstances including out-of-order splicing and appears to rely on occlusion of competing, weak splice sites. Next, we identify scores of splice defects that arise from cryptic splice sites at exon junction sequences. Two key sources of evidence implicate exon junction sequences as sources of cryptic splice sites. First, we validate that cryptic splice donors and acceptors are regenerated at exon junctions. Second, we elucidate that even poor matches to consensus splice motifs can act as functional splice sites at exon junctions. While these sites are suppressed on pre-mRNAs, we find that silencing is also required on mRNAs to prevent further resplicing. Our results suggest that exon junction sequences are a source of cryptic 5’ and 3’ SS, and provides the basis for an intrinsic requirement of the EJC to suppress accidental activation. Overall, our findings broaden a newly appreciated, ancestral function of the EJC, and emphasize that bypass of this regulatory process via cDNA constructs can have unexpected deleterious consequences.

Results

EJC depletion leads to activation of spurious junctions

Recently, Roignant and colleagues reported RNA-seq datasets from S2 cells depleted for core EJC factors eIF4AIII, tsu (Y14) and mago [28]. We re-examined these data for splicing defects, and paid particular attention to spurious splice site usage. We utilized MAJIQ to acquire currently unannotated junctions (3606 novel splice sites supported by ≥5 split reads in the aggregate data), of which 1677 were >2-fold upregulated in at least one EJC-KD condition. As the three core EJC factors are mutually required for stable EJC association at exon-exon junctions, we might expect these to reveal a set of common molecular defects. Indeed, there was both substantial and significant overlap in novel junctions amongst all three conditions (p-value < 1x10-8 for three-way overlap), and 876 junctions were elevated in two out of three EJC-KD datasets (S1A Fig). To introduce further stringency, we also filtered for >2-fold PSI change in 2/3 EJC depletions, yielding 573 spurious junctions from 386 genes (S1B Fig and S1 Table). These genes are diverse, with gene ontology (GO) analysis comprising diverse cellular processes including system development and signaling (S2 Table).

The most frequent spurious junctions involved activation of alternative 5’ or 3’ SS that mapped to exons of canonical transcripts–we refer to these sites as exonic 5’ SS or 3’ SS. The other major classes were novel alternative splicing and activation of SS that mapped to introns (intronic SS) (Fig 1A). These are expected to delete exonic sequence (alternative 5’ or 3’ SS) or insert intronic sequence (intronic SS), relative to canonical mRNA products. We depict straw as an example of aberrant splicing occuring at a constitutive exon-exon junction (Fig 1B). Here, depletion of eIF4AIII, tsu and mago, but not lacZ control, all induced high-frequency usage of a novel exonic, alternative 5’ SS that joins to the constitutive 3’ SS 3248 nt downstream. Importantly, this presumably defective transcript comprises the major isoform in all three core-EJC knockdowns, as it removes 91 nt of coding sequence and is thus out of frame. An additional example of a cryptic exonic 3’ SS from the mask gene is shown in Fig 1C.

Fig 1. Transcriptome-wide de novo alternative splicing upon depletion of functional Exon Junction Complex.

Fig 1

(A) Overview of upregulated de novo splice junctions in EJC-depleted cells. Top: schematic of cryptic 5’ and 3’ SS. In this toy gene model, canonical pre-mRNA exons and introns are depicted as blue boxes and black lines. The ends of these introns are marked by splice signatures (GU: donor and AG: acceptor, shown in black). Cryptic splice sites identified in the EJC LOF datasets can be found within sequences that are normally exonic or intronic. These sites and the putative de novo intron are shown as red text and dashed lines. Bottom: Pie chart indicating the distribution of different splice junction classes. (B) Sashimi plot depicting HISAT2-mapped sequencing coverage along a portion of straw, which has defective splicing under core-EJC LOF. The gene model depicts the location of the cryptic 5’ SS relative to the annotated 5’ SS. Junction spanning read counts mapping to the canonical junction are circled, whereas cryptic junction read counts are squared. Note that spliced reads mapping to the cryptic junction are found in eIF4AIII-, mago- and tsu-KD but not the control comparison. EJC-CLIP [29] shows recruitment of EJC to exon-exon junctions. Region containing the cryptic 5’ SS has been zoomed on the right. (C) Sashimi plot depicting RNA-seq coverage at the mask gene, where depletion of the EJC (shown here, eIF4AIII-RNAi) results in utilization of a cryptic exonic 3’ SS. (D) Schematic for rt-PCR validation of exonic cryptic splicing, which yields shorter, internally deleted products. (E) Validation of de novo splicing events in core-EJC depleted cells. EJC core components (eIF4AIII, mago, tsu and btz) were depleted from Drosophila S2 cells using dsRNA. After knockdown, eight targets identified in (A) were evaluated using rt-PCR and demonstrated splicing defects (asterisk). Importantly, only knockdown of core-EJC factors yielded cryptic bands, but not btz or control conditions. unkempt (unk) generates several products due to multiple alternative exons included within its rt-PCR amplicon (S1D Fig). # indicates products of unknown identity.

We used rt-PCR to validate de novo splice isoforms in EJC-depleted S2 cells, focusing on the dominant classes of cryptic exonic splice site usage (Fig 1A). For these cases, aberrant usage of cryptic exonic splice sites, either at the 5’ or the 3’ end, will yield internally truncated products that can be distinguished from longer wildtype products (Fig 1D). We selected transcripts with high activation of exonic 5’ and 3’ SS (PSI > 0.2), such as straw, multiple ankyrin repeats single KH domain (mask), baboon and eukaryotic translation initiation factor 4G1 (eIF4G1), but also evaluated targets with moderate changes (0.01< PSI < 0.05) such as Crk oncogene and unkempt. As EJC stabilization during pre-mRNA processing requires eIF4AIII, tsu and mago, but not btz, we utilized knockdown of btz and lacZ as controls (S1C Fig). We designed rt-PCR primers that mapped to each mRNA sequence with the cryptic splicing event nested within each amplicon (S2 Fig). For all eight genes tested, we observed splicing defects only under core-EJC (eIF4AIII, tsu and mago) knockdown conditions (Fig 1C). We note that our rt-PCRs proved sensitive enough to detect products that appeared abundant as well as those that were lowly expressed. In the case of unk, we detected the known complement of annotated alternative splice isoforms, but also detected the expected spurious product under EJC LOF (Figs 1C and S1D). These data provide stringent validation of our annotation of spurious junctions, and highlight a previously unappreciated quality control function of the Drosophila EJC.

The EJC suppresses cryptic exonic 3’ SS during pre-mRNA processing

These alterations in transcript processing were reminiscent of how the human EJC, recruited to exon junctions, directly influences the splicing of neighboring introns [10,11]. Accordingly, we examined the mechanism of EJC-regulated splicing defects in Drosophila. We began by examining transcripts with spurious 3’ SS that mapped to exons on wildtype transcripts. These represent a large proportion of de novo events observed in our analysis, and are predicted to cause broad loss of mRNA sequences. Cryptic 3’ SS exhibit strong positional bias and cluster specifically around canonical exon junctions (Fig 2A). However, while cryptic 3’ SS contain the invariant 3’ AG dinucleotide (S3A Fig), quantitative assessment of SS strength indicated broad variation (Fig 2A). In fact, most activated 3’ SS in this category are extremely weak and would not normally be considered functionally competent, especially when considering their sheer frequency in the transcriptome at large. We also considered a scenario in which weak cryptic 3’ SS might be supported by strong branch point sequences (BP). To evaluate this, we first bioinformatically derived a branch point motif by analyzing intronic sequences upstream of canonical Drosophila 3’ SS (S3B Fig). We then assessed the presence and quality of potential BP motifs 15-45 nt upstream of spurious 3’ SS, and found that the distribution of BP motifs was similar between weak and strong cryptic splice sites (S3C Fig). Notably, a substantial fraction of splice sites derepressed in EJC-depleted cells bore weak 3’ SS and lacked overt BPs. Thus, it was important to manipulate these RNA substrates to understand their splicing capacities more directly.

Fig 2. EJC-depletion leads to activation of cryptic 3’ splice sites.

Fig 2

(A) Depiction of 3’ SS position of spurious junctions relative to exon-exon boundaries as density and dot plot. The dot plot indicates splice site scores as calculated via NNSPLICE. Horizontal dashed line depicts threshold for strong 3’ SS, and vertical dashed lines specify 50 nt flanking exon-exon junctions. (B) Sashimi plot depicting HISAT2-mapped sequencing coverage along a portion of CG7408, which has a cryptic 3’ SS that is activated under core-EJC LOF. Junction spanning read counts mapping to the canonical junction are circled, whereas cryptic junction read counts are squared. Note that spliced reads mapping to the cryptic junction are found in eIF4AIII, mago and tsu KD but not the control comparison. EJC-CLIP [29] shows recruitment of EJC to exon-exon junctions. (C) Validation of CG7408 cryptic 3’ SS activation in core-EJC, but not btz or lacZ KD conditions. (D) Schematic of CG7408 splicing reporters. Exons 1–4 (introns included) were cloned and subjected to further manipulation. Locations of deleted introns (Δ), as well as a construct lacking all introns (mRNA) are included. For reference, the position of the cryptic 3’ SS is marked on exon 2. genomic+spacer represents modified versions of the genomic splicing reporter with insertions of 36–48 nt spacer sequences on exon 2. (E) rt-PCR of reporter (D) constructs ectopically expressed in S2 cells demonstrates that intron 2 is required for accurate processing of the minigene. Canonical and cryptic products are indicated. (F) Cryptic splicing is detected with the inclusion of 36–48 nt spacer sequences. (G) Schematic of out-of-order splicing and positional requirement of the core-EJC for accurate 3’ SS definition.

We selected CG7408 as a paradigm: it reproducibly exhibited defective splice isoforms in all core-EJC knockdowns (Fig 2B), but its putative 3’ SS is extremely weak (NNSPLICE score of 0.29, Fig 2A) and poorly conserved (S3D Fig). We used rt-PCR to validate the expected transcript defects in EJC-depleted cells (Fig 2C). The wildtype splicing pattern of this locus (intron 1) involves three alternative 3’ SS (A3’SS), all of which are activated in S2 cells as evidenced by RNA sequencing as well as rt-PCR (Figs 2B, 2C and S3D). The dominant isoform yields the longest product and utilizes an annotated 3’ SS that is stereotypically strong in comparison to the cryptic 3’ SS (NNSPLICE score of 0.91). Activation of the spurious 3’ SS, which lies downstream of all three annotated A3’SS, yields a product lacking 183 nt relative to the dominant wildtype transcript. We constructed a minigene bearing exons 1–4 of wildtype CG7408, allowing us the opportunity to explore aberrant processing (Fig 2D, genomic). When transfected into S2 cells, this reporter produced transcripts that indicated use of annotated A3’SS (Fig 2E, genomic and Fig 2C, lacZ). Importantly, a reporter lacking all introns, i.e., mimicking an mRNA expression construct, yielded a single wildtype product (Fig 2D and 2E, mRNA). Thus, intronless CG7408 transcripts that cannot recruit EJC, also do not undergo further processing.

Next, we explored our minigene reporter by testing for potentially distinct consequences of EJC recruitment to individual CG7408 exon junctions, by deleting each intron in turn (Fig 2D—Δi1, Δi2 and Δi3). These manipulations should only abolish EJC recruitment at individual exon junctions that do not require splicing due to intron deletion. Δi1 only produced wildtype transcript and Δi3 produced wildtype isoforms at the same proportions as the genomic construct (Fig 2E). By contrast, deletion of intron 2 yielded aberrant transcripts through activation of the same weak spurious 3’ SS identified in core-EJC knockdown datasets (Fig 2E, Δi2). These tests emphasize a functional requirement of intron 2 for correct processing of CG7408 and demonstrate that even poor matches to consensus splice sites (i.e., the CG7408 cryptic 3’ SS) can be potently activated in the absence of the EJC.

How is the EJC involved in suppression of cryptic 3’ SS near canonical exon junctions? In human cells, the EJC can directly mask cryptic 3’ SS. Based on the close clustering of these sites around the position of EJC recruitment (Fig 2A), we reasoned that Drosophila EJC may also occlude important features of the 3’ SS, such as the branchpoint, polypyrimidine tract or 3’ intron junction that base-pairs with the U2 snRNP complex. In the specific case of CG7408, we examined published EJC-CLIP [29] to reveal that the spurious 3’ SS directly overlaps the location of EJC recruitment in wildtype cells (Fig 2A). This provides a plausible basis for testing our hypothesis. Importantly, it must be noted that this model requires removal of intron 2 prior to intron 1 (out-of-order splicing) to allow EJC masking of the cryptic 3’ SS (Fig 2G). We tested this hypothesis by separating the cryptic 3’ SS on our genomic reporter from the site of EJC recruitment, by inserting a 36 nt spacer consisting of the Flag epitope tag sequence (Fig 2D, genomic+Spacer). Unlike the genomic construct, which yields only annotated splice isoforms, the genomic+Flag variant yielded truncated transcripts, consistent with derepression of the cryptic 3’ SS (Fig 2F, genomic vs +Flag). This result supports a model in which Drosophila EJC masks cryptic 3’ SS.

However, an alternate possibility is that the Flag spacer sequence might unknowingly bear a splicing enhancer that activates the spurious 3’ SS. To test this scenario, we substituted additional spacers from other epitope tags, Myc and HA. As these variants have different primary sequences, these test whether utilization of cryptic 3’ SS was likely to result from unmasking, rather than enhancement. Both Myc and HA spacer variant constructs generated the same aberrantly spliced products as the Flag spacer (Fig 2F). Thus, our data supports a model in which the Drosophila EJC aids accurate SS selection during pre-mRNA processing by masking cryptic 3’ SS.

We emphasize that these data support a mechanism in which intron 2 is excised first, and that out-of-order splicing mediates correct definition of the annotated intron 1 3’ SS (Fig 2G). To gain direct transcript evidence for this, we examined recently published nanopore analysis of co-transcriptional processing (nano-COP) RNA-seq data, which was used to document that splicing order does not necessarily following the order of transcription [30]. CG7408 lacked sufficient read depth and did not yield informative reads in nano-COP data. However, we found two genes with validated EJC-suppressed cryptic splicing (unkempt and CkIIβ) with out-of-order spliced long reads, for which out-of-order intermediately spliced products are inferred to recruit EJC to spurious 3’ SS (S4 Fig). While out-of-order splicing has been documented as a phenomenon [3034], it has generally been unclear if out-of-order splicing has impact on accurate pre-mRNA maturation. These experiments and analyses, along with recent work by Gehring and colleagues [10], demonstrate loci for which out-of-order splicing is critical for proper mRNA maturation.

The EJC prevents cryptic exonic 5’ SS activation during pre-mRNA processing

We next used analogous strategies to study cryptic exonic 5’ SS. These sites represent ~35% of novel splice junctions upregulated under EJC-depleted conditions and are expected to be deleterious to mRNA processing fidelity. Bioinformatic analyses show cryptic 5’ SS share general structural properties with 3’ SS, such as clear preference in the vicinity of exon junctions but distribution across a wide range of strengths (Figs 3A and S5A).

Fig 3. EJC-depletion leads to activation of cryptic 5’ splice sites.

Fig 3

(A) Metagene of cryptic 5’ SS position relative to exon-exon boundaries as density and dot plot. The dot plot indicates splice site scores as calculated via NNSPLICE (see Materials and Methods). Horizontal dashed line depicts threshold for strong 3’ SS, and vertical dashed lines specify 50 nt flanking exon-exon junctions. (B) Sashimi plot depicting HISAT2-mapped sequencing coverage along a portion of CG3632, which has a cryptic 5’ SS that is activated under core-EJC LOF. Junction spanning read counts mapping to the canonical junction are circled, whereas cryptic junction read counts are squared. Note that spliced reads mapping to the cryptic junction are found in eIF4AIII, mago and tsu KD but not the control comparison. (C) Validation of CG3632 cryptic 5’ SS activation (asterisk) in core-EJC, but not btz or lacZ KD conditions. (D) Schematic of CG3632 splicing reporters. Exons 13–15 (introns included) were cloned and subjected to further manipulation. Locations of deleted introns (Δ), as well as a construct lacking all introns (mRNA) are included. The position of the cryptic 5’ SS is marked on exon 14, and was mutated in Δi13+SD mut. (E) rt-PCR of reporter (D) constructs ectopically expressed in S2 cells demonstrates that intron 13 is required for accurate processing of the minigene. Canonical products are indicated by the line and cryptic products by an asterisk.

We selected CG3632 for mechanistic tests, as core-EJC knockdown activated a poorly conserved, weak cryptic 5’ SS (Figs 3B, S5B and S5C–NNSPLICE score of 0.54) on exon 14. Using rt-PCR and Sanger sequencing, we validated that EJC-depletion induces a defective CG3632 isoform lacking 71 nt of coding sequence (Fig 3C).

We hypothesized that the EJC, recruited to the exon 13/14 junction, suppresses the cryptic 5’ SS on exon 14 and activates the canonical 5’ SS during removal of intron 14. We tested this using a minigene reporter consisting of exon 14 (containing the cryptic 5’ SS) and its immediately flanking introns and exons (Fig 3D, genomic). Expression of this reporter in S2 cells predominantly resulted in the canonical product, but we also observed a minor amount of cryptic 5’ SS activation (Fig 3E, genomic). As a negative control, we generated a version lacking both introns (Fig 3D, Δi13+14), which produced the expected mRNA (Fig 3E, Δi13+14). Notably, removal of intron 13 alone (Fig 3D, Δi13), mimicking loss of EJC recruitment at the exon 13/14 junction, yielded high levels of cryptic 5’ SS activation (Fig 3E, Δi13) that were fully suppressed by mutation of the cryptic 5’ SS in the Δi13 reporter (Fig 3D and 3E, Δi13+SD mut). Altogether, these data support that deposition of the EJC during pre-mRNA processing suppresses cryptic 5’ SS during subsequent intron removal.

The EJC suppresses recursive splice sites

Given that the EJC suppresses both 5’ and 3’ SS, a potentially more complex scenario might exist if both types of cryptic splice sites were to be activated in the vicinity of each other. We inspected our catalog of spurious junctions for this possibility, and considered that even modest matches to consensus splice sites (Figs 2A and 3A) might serve as viable candidates for further evaluation. Interestingly, many sequences at exon junctions were potentially able to regenerate weak splice sites after intron removal, reminiscent of the process of recursive splicing (RS) [35,36].

We first investigated a spurious junction within Casein kinase IIβ (CkIIβ), where core-EJC LOF led to loss of 54 nt of canonical mRNA sequence (S6A and S6B Fig). Assessment of the novel 3’ SS on exon 3 revealed that it lacks a polypyrimidine tract and is a poor match to the consensus (Fig 4A). On the surface, the mechanism of cryptic 3’ SS activation on CkIIβ might appear similar to that of CG7408 (Figs 2F and S6D, path 2). However, upon examining CkIIβ for splice sites, we found an additional poor recursive 5’ SS at the beginning of exon 3 (Fig 4A). Therefore, we imagined an alternate scenario, whereby dual cryptic 5’ and 3’ SS might be derepressed upon EJC loss, leading to resplicing (S6D Fig, path 1). Crucially, whether one-step splicing (via alternative splicing) or resplicing (via recursive splicing event), the resulting mRNA products are indistinguishable (Fig 4A). Therefore, we devised reporter tests to clarify the underlying mechanism.

Fig 4.

Fig 4

EJC-depletion leads to activation of dual cryptic splice sites and resplicing of mRNA. (A) Above: Schematic of resplicing splicing versus alternative resplicing, both of which would yield the same aberrant mRNA product. Below: Sequence of CkIIβ transcript lost due to cryptic splicing. Cryptic 3’ SS activated is highlighted in red, as well as a potential regenerated 5’ SS. Scores listed are generated by NNSPLICE. Conservation across Drosophilid family is shown. (B) Schematic of CkIIβ splicing reporters. Exons 2–4 (introns included) were cloned and subjected to further manipulation. Locations of deleted introns (Δ), as well as a construct lacking all introns (mRNA) are included. For reference, the position of the cryptic 3’ SS and potential 5’ recursive splice sites is marked on exon 3. (C) rt-PCR of CkIIβ reporter constructs in S2 cells demonstrates that introns are required for accurate processing of the minigene. Canonical and cryptic products are indicated. (D) Validation of CG31156 cryptic 5’ SS activation in core-EJC, but not btz or lacZ KD conditions. (E) Schematic of CG31156 splicing reporters with and without introns. Location of potential 3’ recursive splice site on exon 2 is indicated along with conservation scores. (F) rt-PCR of reporter constructs in S2 cells demonstrates that introns are required for accurate processing of the minigene. Canonical and cryptic products are indicated.

We first used rt-PCR to validate that core-EJC knockdown resulted in substantial activation of a truncated CkIIβ splice isoform corresponding to RNA-seq data (S6C Fig). We then analyzed a series of splicing minigenes (Fig 4B). Expression of CkIIβ exons 2–4 with all introns present produced a single product with the expected introns spliced out (Fig 4C, genomic). We precisely tested the positional necessity of the EJC at each exon junction by deleting each intron (Fig 4B, Δi2 and Δi3). These reporters also underwent normal splicing (Fig 4C, Δi2 and Δi3), demonstrating that CkIIβ processing defects were in fact mechanistically distinct from those determined for CG7408. Strikingly, upon testing a construct with both introns deleted, we observed a switch to truncated product output, corresponding to activation of the unannotated recursive 5’ SS and 3’ SS (Fig 4B and 4C, mRNA). This supports a model where the EJC is required at multiple positions to repress spurious 5’ and 3’ SS simultaneously (S6D Fig, path 1).

We characterized another instance of dual cryptic splice site within CG31156, albeit of a different flavor. Here, sashimi plots indicate activation of an exonic 5’ SS within exon 2 (S7A and S7B Fig) and we validated this 110 nt deletion isoform using rt-PCR (Fig 4D). Importantly, based on these data alone, it would be reasonable to predict this as a case of alternative cryptic 5’ SS activation. However, we noticed that removal of the canonical intron 2 regenerates a putative recursive 3’ SS at the exon 2/3 boundary (Figs 4E and S7C). Therefore, we examined reporters to examine the mechanism underlying this unwanted splicing pattern. Expression of the genomic reporter that required intron removal yielded the expected mRNA product (Fig 4F, genomic). Conversely, deletion of the intron and expression of the mRNA resulted in the truncated re-spliced product (Fig 4F, mRNA). Accordingly, these data again indicate that the EJC represses dual cryptic splice sites during mRNA processing (S7D Fig).

Cryptic recursive splice sites suppressed by the EJC exhibit atypical properties

We emphasize that these instances of recursive splice sites (RSS) are quite distinct from those studied previously in Drosophila. Fly genomes are known to contain hundreds of RSS for which the hybrid 5’/3’ splice sites are highly conserved, flanked by short cryptic downstream exons, and highly biased to reside in long introns (mean length ~50 kb) [36,37]. It has been suggested that recursive splicing aids processing of long introns; however, it is also conceivable that it is easier to capture RS intermediates within long introns. The examples of cryptic RSS on the CkIIβ and CG31156 transcripts clearly deviate from canonical RSS architectural properties, i.e., they are hosted in short introns and exhibit modest to poor conservation. Moreover, the example of a recursive 3’ SS in CG31156 is to our knowledge the first validated instance, and represents a conceptually novel RSS location. Importantly, the relevant AG dinucleotide in the CG31156 3’ recursive splice site is not preserved beyond the closest species in the melanogaster subgroup (S7C Fig), and the amino acids encoded by the functional 5’ RSS in CkIIβ diverge with clear wobble patterns (Fig 4A). Thus, these examples of cryptic exonic recursive splicing are functional, but evolutionarily fortuitous.

The EJC protects spliced mRNAs from resplicing

Since many genes span large genomic regions, cDNA constructs have been a mainstay of directed expression strategies. It is generally expected that these should be effective at inducing gain-of-function conditions, yet cDNA constructs are not typically vetted for proper processing. Our finding of dual cryptic splice sites on transcripts was alarming because in both cases, we observed resplicing on mRNA constructs (Fig 4C and 4F). To reiterate, the EJC prevents dual cryptic SS from resplicing on transcript segments that have already undergone intron removal, but such protection will be missing from intronless cDNA copies.

We were keen to assess the breadth of this concept. To do so, we examined the sequence of mRNAs bearing EJC-suppressed cryptic SS, and looked for additional unidentified, complementary SS. Notably, since resplicing would have to map to a canonical junction, we looked for regenerated SS at exon junction sequences. An initial survey for SS invariant dinucleotide signatures (AG for 3’ SS and GT for 5’ SS) indicated that 64/118 junctions with cryptic 3’ SS and 104/183 junctions with cryptic 5’ SS were compatible with resplicing. The fact that over half of both classes of cryptic splicing events were potentially compatible with resplicing might at first glance seem like a tremendous enrichment. However, it does in fact reflect fundamental features of extended consensus splice sequences that basepair with the spliceosome, namely the U1 snRNP and U2AF35 binding sites, respectively (Fig 5A-top). Quantification of these sequences indicated a range of regenerated 5’ and 3’ SS at exon junctions, with at least 59 junctions resembling strong SS (Fig 5B, NNSPLICE>0.75). However, as several cryptic 5’ and 3’ SS amongst our validated loci (Figs 14) were extremely poor, with functional dual cryptic splice sites in CkIIβ scoring at only 0.13 and 0.26 (Fig 4A), the functional breadth of this phenomenon is undoubtedly broader. Therefore, we imagined a scenario where a core function of the EJC is to repress splice sites that were regenerated at exon junctions as a consequence of intron removal using canonical splice sites (Fig 5A-bottom).

Fig 5. Inherent features of splice sites predispose mRNA resplicing.

Fig 5

(A) Model for mRNA re-splicing. Top, Binding sites of U1 snRNA and U2AF35 define the 5’ SS and 3’ SS, respectively, but also impose constraints on flanking exonic sequences that intrinsically regenerate splice site mimics in a recursive fashion. (Bottom) When located in proximity to another cryptic splice site, these can lead to mRNA resplicing in the absence of the EJC. An example of dual cryptic splice sites with a regenerated 3’ SS is shown, but this can also occur with a regenerated 5’ SS. (B) Comparison of splice site strengths for cases of dual cryptic splice site activation. Cases that contain regenerated 3’ and 5’ splice sites at exon junctions and their structures are schematized and distinguished by red and blue dot. Dashed lines mark thresholds for reasonably strong splice sites. (C) Re-splicing on cDNAs. Constructs bearing cDNA segments of baboon, eIF4G1 and straw were expressed in S2 cells and yielded re-spliced amplicons. Gene specific primers that can amplify both endogenous and ectopic products only show re-splicing from cells expressing cDNA reporters. To verify this directly reflects expression from the cDNA reporters, we tested amplicons that include a vector-specific primer, which yields larger bands relative to the gene-specific primers. These also demonstrate mostly re-spliced products.

Nevertheless, as this model cannot be explicitly distinguished from alternative splicing without experimental tests, we selected additional loci for analysis. Therefore, we constructed partial cDNA constructs for three genes, encompassing regions we had validated as subject to EJC-suppression of cryptic splicing (Fig 1C), and selected targets that survey a range of regenerated SS strengths. These include straw, which yields a strong 3’ RSS (NNSPLICE score of 0.98) after removal of intron 3; eIF4G1, which regenerates a moderate 5’ RSS (NNSPLICE score of 0.64) after processing of intron 10; and baboon, which produces an exceptionally poor 3’ RSS (NNSPLICE score of 0) after removal of intron 4, bearing only the AG dinucleotide.

In contrast to the endogenous genes which produced a single amplicon, expression of all three cDNA constructs yielded substantial re-spliced products, supporting our view that the EJC prevents activation of dual cryptic SS on mRNAs, including cryptic SS at exon junction sequences (Fig 5C). Unexpectedly, SS strength did not correlate with levels of re-splicing. Indeed, the majority of transcripts from all three reporters were truncated, including from baboon. Furthermore, the eIF4G1 reporter yielded three truncated products, suggesting that other sequences may also serve as cryptic SS. As these examples of re-splicing occur on coding regions of the transcript, all of them either delete amino acids or generate frameshifts (S8 Fig).

We conclude that many cDNA constructs are potentially prone to resplicing due to loss of protection afforded by the EJC. Moreover, we propose there are distinct classes of cryptic SS within exon junction sequences. The first, examples of which were documented previously, and extended in this study, comprise strong, autonomous splice donors that occur at the 5’ ends of exons and are involved in recursive splicing [10,11,3538]. The second class, which we discover in this study, includes the auxiliary, exonic remnants of canonical splice sites subsequent to intron removal. Crucially, these are weak and are not expected to function as autonomous splice sites, but they can nevertheless become substantially activated under EJC loss-of-function conditions.

Discussion

Conserved role for the EJC to repress cryptic splicing and its regulatory implications

Although introns are not essential for gene expression, they play important facilitatory roles by enhancing export and translation in part through recruitment of the EJC during splicing. Subsequently, it was recognized that once deposited, the EJC also promotes accurate gene expression by regulating processing of neighboring introns. Recently, in the mammalian setting, the role of the EJC during pre-mRNA splicing was extended to include suppression of cryptic splice sites [10,11].

Here we reveal that the fly EJC similarly plays a broad role in direct suppression of cryptic splice sites at exon-exon junctions, owing to its characteristic deposition. Thus, we now appreciate that concealment and suppression of cryptic splice sites is a conserved EJC activity [10]. Importantly, the positional recruitment of the EJC during splicing is conserved and sequence-independent [18]. Thus, we infer this function should also be independent of splice site divergence between phyla, as well as splice site strength, and should not require accessory components. In contrast, non-conserved roles of the EJC appear to rely on integration within and diversification of distinct functional networks. For example, while the Upf (Up-frameshift) proteins coordinate NMD across eukaryotes [39], the mechanisms differ. In mammals, NMD is coordinated with intron removal through direct interactions between the EJC and Upf3 [16,17,40]. However, these interactions are not found in invertebrates, and consequently the invertebrate EJC is not involved in NMD [19].

In addition to pre-mRNAs, we show that the EJC also suppresses cryptic splice sites within spliced mRNAs. Although this mechanism cannot be distinguished from alternative splicing (Fig 4A) without directed experimentation, we readily detect re-splicing on all cDNA constructs tested. Unexpectedly, while these junctions appear to contain just one cryptic SS, our data indicates that these transcripts contain secondary cryptic splice sites that mediate resplicing. Importantly, we validate that even poor matches to SS consensus motifs are competent for re-splicing. Curiously, as all of our demonstrated examples involve a recursive event at either the 5’ or 3’ cryptic SS, our findings broaden a phenomenon that was previously described within long introns [36,37]. Furthermore, canonical SS sequences that undergo base pairing interactions with U1 snRNA (5’ SS) and U2AF35 (3’ SS) have motifs AG|GURAGU and YAG|GU [5,41]. It is noteworthy that core splice site signals contain bases that are compatible with regeneration of splice sites and that these naturally occur proximal to EJC recruitment sites. Accordingly, we propose that an ancestral function for the conserved position of EJC deposition may be to prevent accidental activation of regenerated splice sites.

Finally, our observations of re-splicing on cDNAs reflect an essential function for introns in protecting mRNA fidelity. For all tested cases of cDNA resplicing on coding sequences, we note deletions of peptide segments or truncations with loss of domains required for protein function. Importantly, these affected targets include essential genes, such as eIF4G1 and activin receptor baboon. In the case of baboon, the 54 nt splicing defect leads to a deletion of 18 amino acids (195–212, S8A Fig). For eIF4G1, re-splicing removes 131 nt of mRNA sequence, alters the open reading frame and leads to protein truncation with loss of the MI and W2 domains (S8B Fig). Finally, re-splicing on straw transcripts also alters reading frame by removing 91 nt of mRNA, and is predicted to remove 2/3 Plastocyanin-like domains (S8C Fig). Thus, our findings have serious implications for functional genomics as well as community genetic studies [42,43], where cDNA expression constructs and collections are often employed with little attention paid to mRNA processing. Altogether, our work uncovers important functions for intron removal and the role of the EJC to protect the transcriptome from unwanted re-splicing.

Materials and methods

Bioinformatic analysis

Datasets

We obtained several published datasets from the NCBI Gene Expression Omnibus or the European Nucleotide Archive for analyses in this study. Core-EJC knockdown RNA-sequencing datasets were reported by the Roignant lab [28]: GSE92389. EJC CLIP datasets were published work by the Ephrussi lab [29]: PRJEB26421. Raw sequencing data was mapped to the Drosophila reference genome sequence (BDGP Release 6/dm6) using HISAT2 [44] under the default settings. Direct chromatin RNA nanopore data (nano-COP) from S2 cells was reported by the Churchman lab [30]: GSE123191. We mapped nano-COP data to the Drosophila reference genome sequence (BDGP Release 6/dm6) using minimap2 with parameters -ax splice -uf -k14.

Splicing analyses

Splice junctions were mapped using the MAJIQ algorithm (2.0) under default conditions [45]. Splice graphs and known/novel local splice variants were defined with the MAJIQ Builder using annotations of known genes and splice junctions from Ensembl release 95 and all BAM files. The MAJIQ Quantifier was used to calculate relative abundances (percent selected index—PSI) for all defined junctions. The resulting data was output into tabular format using the Voila function.

A custom R script was written to process all MAJIQ-defined novel junctions relative to the Ensembl gene annotations and identify de novo EJC-suppressed junctions. First, we quantified usage of all novel junctions by mining mapped libraries (BAM files) for high quality junction spanning reads with at least 8 nt of overhang and no mismatches. These counts were normalized to sequencing depth per library. To identify de novo junctions that may be upregulated, we first selected junctions with at least 5 split reads. In order to enrich for de novo junctions that are suppressed by the EJC pathway, we looked for those with > 2 fold difference in at least 2/3 core-EJC RNAi conditions relative to the lacZ control. To apply further stringency, we also required that the PSI measurements reflect sufficient change between treatment and control conditions. Therefore, we applied an additional filter of PSI fold change > 2 in at least 2/3 core-EJC RNAi conditions. These criteria produced a total of 573 novel junctions. All junctions are reported in S1 Table.

The 5’ and 3’ ends of these junctions were compared against known gene annotations to characterize splice sites. Exonic 5’ and 3’ SS reflect sites that mapped on exons while the other end mapped to a canonical splice junction, and the same process was used to define intronic 5’ and 3’ SS. de novo cases of alternative splicing reflect junctions that utilized annotated splice sites but represented novel connectivity. Sashimi plots were generated using features available on the Integrative Genomics Viewer (IGV) [46].

We generated a custom pipeline to assess recursive splicing potential (Fig 4). Briefly, we identified transcripts that contained cryptic exonic 5’ and 3’ splice sites. For these transcripts, we mapped the position of all splice junctions on the mRNA, which could in theory generate the observed splicing defects. We examined sequences directly downstream of relevant splice junctions to identify potential 5’ recursive splicing and those directly upstream to identify potential 3’ recursive splicing.

We calculated splice site strengths using NNSPLICE (https://www.fruitfly.org/seq_tools/splice.html) [47]. The sequences used for these analyses were obtained from mRNA rather than the genomic context, which may contain intronic sequences as well. To generate nucleotide content plots, splice sites and their indicated flanking sequences were obtained from mRNAs and fed to WebLogo version 2.8.2 [48]. The splice sites are centered in these plots.

Branchpoint analysis

We sought to identify possible branchpoints upstream of spurious 3’ SS. We first derived a BP position weight matrix (PWM) by calling motifs (using MEME) on sequences 15–45 nt upstream of 3’ SS from 10,000 randomly selected introns from Drosophila. This strategy has previously been adopted to identify putative branch point motifs [49,50]. We then used the obtained PWM to find potential BP sequences upstream of spurious 3’ SS using a minimum of 75% PWM match.

Constructs and cell culture

All splicing reporters were cloned into pAC-5.1-V5-His (ThermoFisher Scientific) using compatible restriction sites. We used PCR to amplify minigene splicing reporters from Drosophila genomic DNA, and used site directed mutagenesis to remove specified introns. We used cDNAs to amplify reporters lacking introns. For genes with multiple isoforms (such as CG7408), we cloned the dominant fragment. All primers used for generating constructs and mutagenesis have been summarized in S3 Table.

Transfections were performed using S2-R+ cells cultured in Schneider Drosophila medium with 10% FBS. Cells were seeded in 6-well plates at a density of 1x106 cells/mL and transfected with 200 ng of plasmid using the Effectene transfection kit (Qiagen). Cells were harvested following 3 days of incubation.

Knockdown of EJC factors in S2 cells

The indicated EJC components were knocked down via RNAi (dsRNA-mediated interference) in S2-R+ cells. The MEGAscript RNAi kit (ThermoFisher Scientific) was used to produce dsRNAs required for this experiment. Briefly, DNA templates containing promoter sequences on either 5’ end were produced through PCR with T7-promoter-fused primers. 2 μg of DNA template was transcribed in vitro for 4 hours as recommended by the manufacturer. The products were incubated at 75° C for 5 minutes and brought to room temperature to enhance dsRNA formation. A cocktail of DNaseI and RNase removed DNA and ssRNAs, and the remaining dsRNA was purified using the provided reagents. All dsRNA reagents were verified by running on a 1% agarose gel and quantified by measuring absorbance at 260 nm using a NanoDrop (ThermoFisher Scientific).

For knockdown, 3x106 S2-R+ cells in 1 mL serum free medium were incubated with 15 μg of dsRNA for 1 hour at room temperature. Then, 1 mL of medium containing 20% FBS was added to the cells and the whole mixture was moved to a 6 well plate. Cells were collected after 4 days of incubation.

RT-PCR

After transfection or RNAi treatment, cells were washed in ice cold PBS and pelleted using centrifugation. RNA was collected using the TRIzol reagent (Invitrogen) under the recommended conditions. 5 μg of RNA was treated with Turbo DNase (Ambion) for 45 min before cDNA synthesis using SuperScript III (Life Technology) with random hexamers. RT-PCR was performed using AccuPrime Pfx DNA polymerase (ThermoFisher Scientific) with standard protocol using 26 cycles and primers that were specific to each minigene construct. All primers are listed and described in S3 Table.

Supporting information

S1 Fig. Core-EJC depletion yields broad activation of de novo splice junctions.

(A) Strong overlap of de novo splice junctions between core-EJC knockdown conditions. The Venn diagram depicts which of 1677 junctions with at least 5 split reads had > 2-fold split read changes between treatment and controls. p-value for three-way overlap was calculated using a permutation test with 10^8 tests. (B) Strong overlap of high-confidence de novo splice junctions between core-EJC knockdown conditions. The Venn diagram depicts which of 876 junctions with at least 5 split reads and > 2-fold split read changes also show > 2-fold changes in percent selected index (PSI) between treatment and controls. p-value for three-way overlap was calculated using a permutation test with 10^8 tests. (C) Knockdown of EJC factors in S2 cells using dsRNA. quantitative rt-PCR of core-EJC and btz transcripts after dsRNA treatment. (D) Sashimi plot illustrating the expression of annotated alternative isoforms for unkempt (unk) in S2 cells. The location of rtPCR primers and alternative isoforms are included.

(TIF)

S2 Fig. Locations of rtPCR primers within target transcripts.

Gene models for genes tested in Fig 1C and primers are illustrated from the UCSC genome browser. Mapping of products obtained from spurious splicing indicate transcript changes.

(TIF)

S3 Fig. A majority of cryptic 3’ SS activated under EJC-loss are weak.

(A) Nucleotide content of cryptic 3’ SS. These sequences, apart from the invariant AG dinucleotide show poor strength. (B) BP motif obtained by analysis of 10000 annotated introns. (C) Plot indicating the relationship between BP motif and spurious 3’ SS strength. (D) Example of a weak cryptic 3’ SS (NNSPLICE score of 0.29) found on the CG7408 transcript. Sashimi plot indicating splice junction counts in EJC LOF and control datasets. The locations of annotated and spurious 3’ SS are shown. Conservation of the weak splice site is depicted using the multiple alignment format on the UCSC genome browser, as well as phyloP and phastCons scores. The location of spacer sequences schematized in Fig 2D is marked.

(TIF)

S4 Fig. Evidence for out-of-order intron removal in unkempt and CkIIβ.

(A) Evidence for out-of-order intron removal for unkempt. Top: Sashimi plot indicating the expression of annotated and spurious splicing using control and mago knockdown RNA sequencing datasets. The location of the spurious 3’ SS relative to the wildtype transcript isoforms is marked. Below: nano-COP reads mapping to the portion of unkempt that undergoes spurious splicing. Within the reads, boxes represent coverage and lines represent skipped coverage due to splicing. Note that skipped read coverage maps to the location of annotated introns. Reads that indicate out-of-order processing are marked–here the downstream intron is removed, but an upstream intron (according to the annotated models) is not processed. Within this locus, there were no examples of reads with all introns removed. (B) Evidence for out-of-order intron removal for CkIIβ. As in (A), the top shows a sashimi plot whereas the bottom represents nano-COP reads. For this locus, there was evidence for fully spliced, fully unspliced and partially spliced products. We identified two instances of out-of-order intron removal and one instance of ordered intron removal.

(TIF)

S5 Fig. A majority of cryptic 5’ SS activated under EJC-loss are weak.

(A) Nucleotide content of cryptic 5’ SS. (B) Schematic of a de novo splicing event detected on the CG3632 transcript. Validation of splicing defects shown on the right. (C) Cryptic 5’ SS (NNSPLICE score of 0.54) found on the CG3632 transcript. Conservation of the weak splice site is depicted using the multiple alignment format on the UCSC genome browser, as well as phyloP and phastCons scores.

(TIF)

S6 Fig. de novo splicing on CkIIβ is a result of dual cryptic splice site activation.

(A) Sashimi plot depicting HISAT2-mapped sequencing coverage along a portion of CkIIβ, which has a cryptic 3’ SS that is activated under core-EJC LOF. Junction spanning read counts mapping to the canonical junction are circled, whereas cryptic junction read counts are squared. Note that spliced reads mapping to the cryptic junction are found in eIF4AIII, mago and tsu but not the control comparison. (B) Schematic of a de novo splicing event detected on the CkIIβ transcript. (C) Validation of CkIIβ cryptic 3’ SS activation in core-EJC, but not btz or lacZ KD conditions. (D) Models that explain the CkIIβ splicing defects. Path 1 and 2 reflect alternate orders of intron removal. Crucially, path 1 leads to EJC-suppressed cryptic splicing on mRNAs using the indicated 5’ recursive splice site and a cryptic 3’ SS, whereas path 2 can also produce a splice defect after removal of intron 2.

(TIF)

S7 Fig. de novo splicing on CG31156 is a result of dual cryptic splice site activation.

(A) Sashimi plot depicting HISAT2-mapped sequencing coverage along a portion of CG31156, which has a cryptic 5’ SS that is activated under core-EJC LOF. Junction spanning read counts mapping to the canonical junction are circled, whereas cryptic junction read counts are squared. Note that spliced reads mapping to the cryptic junction are found in eIF4AIII, mago and tsu but not the control comparison. (B) Schematic of a de novo splicing event detected on the CG31156 transcript. (C) Conservation of the cryptic 5’ SS (NNSPLICE score of 0.54) and a potential 3’ recursive splice site (NNSPLICE score of 0.98) found on the CG31156 transcript highlighted in green, relative to the gene model. Conservation of the splice site is depicted using the multiple alignment format on the UCSC genome browser, as well as phyloP scores. Canonical splice sites are highlighted in yellow. (D) Model of activation of dual cryptic splice sites on the CG31156 transcript. Activation of the cryptic 5’ SS with an additional cryptic 3’ recursive splice sites leads to deletion of 110 nt of mRNA.

(TIF)

S8 Fig. Re-splicing on mRNAs alters translated proteins.

(A-C) Protein and transcript structures are schematized and the location of cryptic resplicing highlighted in blue. (A) Re-splicing on baboon leads to a 54 nt deletion of the mRNA and an 18 amino acid deletion. The deletion does not overlap known domains. Conservation plots for deleted 54 nt region is included. (B) Re-splicing on eIF4G1 leads to a 131 nt deletion, leading to a change in reading frame and truncation of the C terminal domains of eIF4G1. Importantly, critical domains required for eIF4G1 function are lost due to re-splicing. (C) Re-splicing on straw leads to a 91 nt deletion, leading to a change in reading frame and truncation of the protein. Importantly, 2 of 3 Plastocyanin-like domains are lost due to transcript defects.

(TIF)

S1 Table. Drosophila cryptic splice junctions that are repressed by the Exon Junction Complex (EJC).

This table provides the genomic locations, host genes, and classification of de novo unannotated splice junctions discovered in EJC-knockdown data from S2 cells.

(XLSX)

S2 Table. Gene ontology (GO) analysis of genes with cryptic splicing that is repressed by the EJC.

(XLSX)

S3 Table. Oligonucleotide sequences used in this study.

The tabs summarize primers used to clone constructs, to knockdown gene products, and to assess mRNA processing.

(XLSX)

Data Availability

All custom scripts used in this study are reported on the Lai lab GitHub page (https://github.com/Lai-Lab-Sloan-Kettering).

Funding Statement

Work in E.C.L.’s group was supported by the National Institutes of Health (R01-NS083833 and R01-GM083300) and MSK Core Grant P30-CA008748. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Lerner MR, Boyle JA, Mount SM, Wolin SL, Steitz JA (1980) Are snRNPs involved in splicing? Nature 283: 220–224. doi: 10.1038/283220a0 [DOI] [PubMed] [Google Scholar]
  • 2.Zhuang Y, Weiner AM (1986) A compensatory base change in U1 snRNA suppresses a 5’ splice site mutation. Cell 46: 827–835. doi: 10.1016/0092-8674(86)90064-4 [DOI] [PubMed] [Google Scholar]
  • 3.Seraphin B, Kretzner L, Rosbash M (1988) A U1 snRNA:pre-mRNA base pairing interaction is required early in yeast spliceosome assembly but does not uniquely define the 5’ cleavage site. The EMBO journal 7: 2533–2538. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Siliciano PG, Guthrie C (1988) 5’ splice site selection in yeast: genetic alterations in base-pairing with U1 reveal additional requirements. Genes & development 2: 1258–1267. doi: 10.1101/gad.2.10.1258 [DOI] [PubMed] [Google Scholar]
  • 5.Kielkopf CL, Rodionova NA, Green MR, Burley SK (2001) A novel peptide recognition mode revealed by the X-ray structure of a core U2AF35/U2AF65 heterodimer. Cell 106: 595–605. doi: 10.1016/s0092-8674(01)00480-9 [DOI] [PubMed] [Google Scholar]
  • 6.Newman AJ, Norman C (1992) U5 snRNA interacts with exon sequences at 5’ and 3’ splice sites. Cell 68: 743–754. doi: 10.1016/0092-8674(92)90149-7 [DOI] [PubMed] [Google Scholar]
  • 7.Sontheimer EJ, Steitz JA (1993) The U5 and U6 small nuclear RNAs as active site components of the spliceosome. Science 262: 1989–1996. doi: 10.1126/science.8266094 [DOI] [PubMed] [Google Scholar]
  • 8.Dibb NJ, Newman AJ (1989) Evidence that introns arose at proto-splice sites. The EMBO journal 8: 2015–2021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Sadusky T, Newman AJ, Dibb NJ (2004) Exon junction sequences as cryptic splice sites: implications for intron origin. Curr Biol 14: 505–509. doi: 10.1016/j.cub.2004.02.063 [DOI] [PubMed] [Google Scholar]
  • 10.Boehm V, Britto-Borges T, Steckelberg AL, Singh KK, Gerbracht JV, et al. (2018) Exon Junction Complexes Suppress Spurious Splice Sites to Safeguard Transcriptome Integrity. Molecular cell 72: 482–495 e487. doi: 10.1016/j.molcel.2018.08.030 [DOI] [PubMed] [Google Scholar]
  • 11.Blazquez L, Emmett W, Faraway R, Pineda JMB, Bajew S, et al. (2018) Exon Junction Complex Shapes the Transcriptome by Repressing Recursive Splicing. Molecular cell 72: 496–509 e499. doi: 10.1016/j.molcel.2018.09.033 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Le Hir H, Sauliere J, Wang Z (2016) The exon junction complex as a node of post-transcriptional networks. Nature reviews Molecular cell biology 17: 41–54. doi: 10.1038/nrm.2015.7 [DOI] [PubMed] [Google Scholar]
  • 13.Boehm V, Gehring NH (2016) Exon Junction Complexes: Supervising the Gene Expression Assembly Line. Trends in genetics: TIG 32: 724–735. doi: 10.1016/j.tig.2016.09.003 [DOI] [PubMed] [Google Scholar]
  • 14.Schlautmann LP, Gehring NH (2020) A Day in the Life of the Exon Junction Complex. Biomolecules 10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Bonnal SC, Lopez-Oreja I, Valcarcel J (2020) Roles and mechanisms of alternative splicing in cancer—implications for care. Nat Rev Clin Oncol doi: 10.1038/s41571-020-0350-x [DOI] [PubMed] [Google Scholar]
  • 16.Lykke-Andersen J, Shu MD, Steitz JA (2001) Communication of the position of exon-exon junctions to the mRNA surveillance machinery by the protein RNPS1. Science 293: 1836–1839. doi: 10.1126/science.1062786 [DOI] [PubMed] [Google Scholar]
  • 17.Kim VN, Kataoka N, Dreyfuss G (2001) Role of the nonsense-mediated decay factor hUpf3 in the splicing-dependent exon-exon junction complex. Science 293: 1832–1836. doi: 10.1126/science.1062829 [DOI] [PubMed] [Google Scholar]
  • 18.Le Hir H, Izaurralde E, Maquat LE, Moore MJ (2000) The spliceosome deposits multiple proteins 20–24 nucleotides upstream of mRNA exon-exon junctions. The EMBO journal 19: 6860–6869. doi: 10.1093/emboj/19.24.6860 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Nicholson P, Muhlemann O (2010) Cutting the nonsense: the degradation of PTC-containing mRNAs. Biochemical Society transactions 38: 1615–1620. doi: 10.1042/BST0381615 [DOI] [PubMed] [Google Scholar]
  • 20.Singh G, Kucukural A, Cenik C, Leszyk JD, Shaffer SA, et al. (2012) The cellular EJC interactome reveals higher-order mRNP structure and an EJC-SR protein nexus. Cell 151: 750–764. doi: 10.1016/j.cell.2012.10.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Ashton-Beaucage D, Udell CM, Lavoie H, Baril C, Lefrancois M, et al. (2010) The exon junction complex controls the splicing of MAPK and other long intron-containing transcripts in Drosophila. Cell 143: 251–262. doi: 10.1016/j.cell.2010.09.014 [DOI] [PubMed] [Google Scholar]
  • 22.Roignant JY, Treisman JE (2010) Exon junction complex subunits are required to splice Drosophila MAP kinase, a large heterochromatic gene. Cell 143: 238–250. doi: 10.1016/j.cell.2010.09.036 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Malone CD, Mestdagh C, Akhtar J, Kreim N, Deinhard P, et al. (2014) The exon junction complex controls transposable element activity by ensuring faithful splicing of the piwi transcript. Genes & development 28: 1786–1799. doi: 10.1101/gad.245829.114 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Hayashi R, Handler D, Ish-Horowicz D, Brennecke J (2014) The exon junction complex is required for definition and excision of neighboring introns in Drosophila. Genes & development 28: 1772–1785. doi: 10.1101/gad.245738.114 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Brown JB, Boley N, Eisman R, May GE, Stoiber MH, et al. (2014) Diversity and dynamics of the Drosophila transcriptome. Nature 512: 393–399. doi: 10.1038/nature12962 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Westholm JO, Miura P, Olson S, Shenker S, Joseph B, et al. (2014) Genome-wide Analysis of Drosophila Circular RNAs Reveals Their Structural and Sequence Properties and Age-Dependent Neural Accumulation. Cell reports 9: 1966–1980. doi: 10.1016/j.celrep.2014.10.062 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Sanfilippo P, Wen J, Lai EC (2017) Landscape and evolution of tissue-specific alternative polyadenylation across Drosophila species. Genome biology 18: 229. doi: 10.1186/s13059-017-1358-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Akhtar J, Kreim N, Marini F, Mohana G, Brune D, et al. (2019) Promoter-proximal pausing mediated by the exon junction complex regulates splicing. Nature communications 10: 521. doi: 10.1038/s41467-019-08381-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Obrdlik A, Lin G, Haberman N, Ule J, Ephrussi A (2019) The Transcriptome-wide Landscape and Modalities of EJC Binding in Adult Drosophila. Cell reports 28: 1219–1236 e1211. doi: 10.1016/j.celrep.2019.06.088 [DOI] [PubMed] [Google Scholar]
  • 30.Drexler HL, Choquet K, Churchman LS (2020) Splicing Kinetics and Coordination Revealed by Direct Nascent RNA Sequencing through Nanopores. Molecular cell 77: 985–998 e988. doi: 10.1016/j.molcel.2019.11.017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Takahara K, Schwarze U, Imamura Y, Hoffman GG, Toriello H, et al. (2002) Order of intron removal influences multiple splice outcomes, including a two-exon skip, in a COL5A1 acceptor-site mutation that results in abnormal pro-alpha1(V) N-propeptides and Ehlers-Danlos syndrome type I. Am J Hum Genet 71: 451–465. doi: 10.1086/342099 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Pandya-Jones A, Black DL (2009) Co-transcriptional splicing of constitutive and alternative exons. RNA 15: 1896–1908. doi: 10.1261/rna.1714509 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Khodor YL, Rodriguez J, Abruzzi KC, Tang CH, Marr MT 2nd, et al. (2011) Nascent-seq indicates widespread cotranscriptional pre-mRNA splicing in Drosophila. Genes & development 25: 2502–2512. doi: 10.1101/gad.178962.111 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.LeMaire MF, Thummel CS (1990) Splicing precedes polyadenylation during Drosophila E74A transcription. Molecular and cellular biology 10: 6059–6063. doi: 10.1128/mcb.10.11.6059 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Burnette JM, Miyamoto-Sato E, Schaub MA, Conklin J, Lopez AJ (2005) Subdivision of large introns in Drosophila by recursive splicing at nonexonic elements. Genetics 170: 661–674. doi: 10.1534/genetics.104.039701 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Joseph B, Kondo S, Lai EC (2018) Short cryptic exons mediate recursive splicing in Drosophila. Nature structural & molecular biology 25: 365–371. doi: 10.1038/s41594-018-0052-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Duff MO, Olson S, Wei X, Garrett SC, Osman A, et al. (2015) Genome-wide identification of zero nucleotide recursive splicing in Drosophila. Nature 521: 376–379. doi: 10.1038/nature14475 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Hatton AR, Subramaniam V, Lopez AJ (1998) Generation of alternative Ultrabithorax isoforms and stepwise removal of a large intron by resplicing at exon-exon junctions. Molecular cell 2: 787–796. doi: 10.1016/s1097-2765(00)80293-2 [DOI] [PubMed] [Google Scholar]
  • 39.He F, Jacobson A (2015) Nonsense-Mediated mRNA Decay: Degradation of Defective Transcripts Is Only Part of the Story. Annual review of genetics 49: 339–366. doi: 10.1146/annurev-genet-112414-054639 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Le Hir H, Gatfield D, Izaurralde E, Moore MJ (2001) The exon-exon junction complex provides a binding platform for factors involved in mRNA export and nonsense-mediated mRNA decay. The EMBO journal 20: 4987–4997. doi: 10.1093/emboj/20.17.4987 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Kondo Y, Oubridge C, van Roon AM, Nagai K (2015) Crystal structure of human U1 snRNP, a small nuclear ribonucleoprotein particle, reveals the mechanism of 5’ splice site recognition. eLife 4. doi: 10.7554/eLife.04986 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Wei P, Xue W, Zhao Y, Ning G, Wang J (2020) CRISPR-based modular assembly of a UAS-cDNA/ORF plasmid library for more than 5500 Drosophila genes conserved in humans. Genome research 30: 95–106. doi: 10.1101/gr.250811.119 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Yu C, Wan KH, Hammonds AS, Stapleton M, Carlson JW, et al. (2011) Development of expression-ready constructs for generation of proteomic libraries. Methods in molecular biology 723: 257–272. doi: 10.1007/978-1-61779-043-0_17 [DOI] [PubMed] [Google Scholar]
  • 44.Kim D, Langmead B, Salzberg SL (2015) HISAT: a fast spliced aligner with low memory requirements. Nature methods 12: 357–360. doi: 10.1038/nmeth.3317 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Vaquero-Garcia J, Barrera A, Gazzara MR, Gonzalez-Vallinas J, Lahens NF, et al. (2016) A new view of transcriptome complexity and regulation through the lens of local splicing variations. eLife 5: e11752. doi: 10.7554/eLife.11752 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Robinson JT, Thorvaldsdottir H, Winckler W, Guttman M, Lander ES, et al. (2011) Integrative genomics viewer. Nature biotechnology 29: 24–26. doi: 10.1038/nbt.1754 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Reese MG, Eeckman FH, Kulp D, Haussler D (1997) Improved splice site detection in Genie. Journal of computational biology: a journal of computational molecular cell biology 4: 311–323. doi: 10.1089/cmb.1997.4.311 [DOI] [PubMed] [Google Scholar]
  • 48.Crooks GE, Hon G, Chandonia JM, Brenner SE (2004) WebLogo: a sequence logo generator. Genome research 14: 1188–1190. doi: 10.1101/gr.849004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Lim LP, Burge CB (2001) A computational analysis of sequence features involved in recognition of short introns. Proceedings of the National Academy of Sciences of the United States of America 98: 11193–11198. doi: 10.1073/pnas.201407298 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Pai AA, Henriques T, McCue K, Burkholder A, Adelman K, et al. (2017) The kinetics of pre-mRNA splicing in the Drosophila genome and the influence of gene architecture. eLife 6. doi: 10.7554/eLife.32537 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

John M Greally, Teresa Bowman

4 Dec 2020

Dear Dr Lai,

Thank you very much for submitting your Research Article entitled 'The Exon Junction Complex and intron removal prevents re-splicing of mRNA' to PLOS Genetics.

The manuscript was fully evaluated at the editorial level and by independent peer reviewers. While both reviewers found value in examining the conservation of splicing regulation by the exon-junction complex in drosophila, there were several experimental and computational issues that need to be addressed. Moreover, there were substantial concerns about the interpretation and the presentation of the data, which does not sufficiently frame how these new findings fit into the context of what is already known about the connections of the EJC to splicing or what is novel in your work compared to prior studies. Based on the reviews, we will not be able to accept this version of the manuscript, but we would be willing to review a much-revised version. We cannot, of course, promise publication at that time.

Should you decide to revise the manuscript for further consideration here, your revisions should address the specific points made by each reviewer. We will also require a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript.

If you decide to revise the manuscript for further consideration at PLOS Genetics, please aim to resubmit within the next 60 days, unless it will take extra time to address the concerns of the reviewers, in which case we would appreciate an expected resubmission date by email to plosgenetics@plos.org.

If present, accompanying reviewer attachments are included with this email; please notify the journal office if any appear to be missing. They will also be available for download from the link below. You can use this link to log into the system when you are ready to submit a revised version, having first consulted our Submission Checklist.

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see our guidelines.

Please be aware that our data availability policy requires that all numerical data underlying graphs or summary statistics are included with the submission, and you will need to provide this upon resubmission if not already present. In addition, we do not permit the inclusion of phrases such as "data not shown" or "unpublished results" in manuscripts. All points should be backed up by data provided with the submission.

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool.  PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

PLOS has incorporated Similarity Check, powered by iThenticate, into its journal-wide submission system in order to screen submitted content for originality before publication. Each PLOS journal undertakes screening on a proportion of submitted articles. You will be contacted if needed following the screening process.

To resubmit, use the link below and 'Revise Submission' in the 'Submissions Needing Revision' folder.

[LINK]

We are sorry that we cannot be more positive about your manuscript at this stage. Please do not hesitate to contact us if you have any concerns or questions.

Yours sincerely,

Teresa Bowman

Guest Editor

PLOS Genetics

John Greally

Section Editor: Epigenetics

PLOS Genetics

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: The authors have reanalyzed RNA-seq data, previously published by Akhtar et al. 2019, for EJC knockdowns in Drosophila cells. They follow with RT-PCR of specific transcripts and from cells transfected with reporter constructs to provide experimental validation. Overall, they conclude that loss of EJC deposition results in activation of cryptic splice sites, as was found in human cells (Gehring, Mol. Cell 2018). The issue of the extent to which the EJC influences splicing is an interesting one, and I value such data from more than one model system. However, I am not convinced that the data in the current manuscript are sufficiently compelling on their own for many of the conclusions drawn. Rather, they are consistent with an interpretation already made in the human system.

Overall, the writing needs to be more precise, the presentation of the data more complete, and the description of what can and cannot be concluded from the data more accurate.

Specific Comments:

1 -p.2. I do not understand how the authors can justify saying “Unexpectedly, we discover the EJC inhibits scores of regenerated 5' and 3' recursive splice sites on segments that have already undergone splicing”, when this is exactly one of the findings of the Gehring Mol Cell paper.

2 -pp.3-5. The Introduction is overall unclear, muddled, and confusing. The last paragraph is clear, but otherwise the Introduction does not sufficiently represent the history of the EJC in splicing.

3 -p.3. “Cryo-EM structures of prespliceosomal complexes show that U1 snRNA establishes base contacts across the -2 to +6 position for a typical 5’SS…”. This is a rather bizarre statement. It is true, but it seems to assert that U1-5’SS base pairing was discovered by cryo-EM, rather than proven by biochemistry and genetics over 30 years ago.

4 -Fig. 1A. This schematic doesn’t make much sense at first. It is not clear that the blue/black represents the canonical WT splicing isoform, and the labeled splice sites and red lines represent only cryptic sites and splicing.

5 -Fig. 1C, and 2C,E,F. What exactly are these alternative isoforms? There should be Sanger sequencing information of these PCR products provided.

6 -Likewise, what are any of these amplicons supposed to be? The primer binding sites should be shown in a schematic for each gene. Without this information, it is quite difficult to evaluate any of these data.

7 -1C panel 7 is missing an asterisk for the cryptic product.

8 -All the gels have DNA ladders included, but none are labeled, so the reader doesn’t know what size any of the bands are.

9 -p.7. “spurious exonic 3' SS “ and “cluster specifically around exon junctions”, etc. The authors need to adopt more precise language. For the RNA molecule in which the cryptic 3’SS is used, it is the 3’SS and it is not exonic. The authors are comparing to a canonical splicing pattern found in WT cells; they need to be more precise to avoid confusion.

10 -p.8. “Our cryptic junction replaces intron 1”. How can a junction replace an intron?

11 -p.8. “this reporter recapitulated normal splicing through activation of annotated 3' SS”. To what control is this new reporter compared to show that it recapitulates “normal” splicing? No such control is shown.

12 -p.8. “At face value, this appears consistent with the hypothesis that the EJC regulates splicing of flanking introns.” Huh?? This conclusion does not follow from the previous sentences. Perhaps the authors thought they put it elsewhere?

13 -p.8. Language like “pre-processed exon junctions” and “pre-spliced” is confusing and inaccurate.

14 -p.8 and Figure 2 D, E: There is no evidence here that this is related to EJC deposition. An alternative model, not considered, is that i2 deletion brings an exonic enhancer present in e3 close to the cryptic 3’SS found in e2.

15 -Likewise the authors have no evidence for the order of intron removal in CG7408.

16 -Fig. 2F. What is the 36-nt sequence that was added? This is not provided. How do we know that it is a ‘neutral’ sequence? Could it contain a splicing enhancer? (Honestly, it’s not so easy to come up with a neutral sequence.)

17 -p.9 and Fig 2A and 3A. “clear preference in the vicinity of exon junctions but distribution across a wide range of strengths.” What is the X-axis? The vast majority of exons are not 500 nt long. Most are ~100-150 nts, so this schematic just shows that the cryptic 5’SS are found within a distance of a typical exon from the WT 5’SS. It looks like the authors used -500 and +500 sequence from the selected WT exon junction, but these are not necessarily all exonic sequence; however, it is not at all clear what sequence the authors use here.

18 -There are logical inconsistencies. For example, on p.15 the authors correctly admit the they cannot distinguish recursive splicing from alternative splicing; yet, in the next sentence state that they “readily detect re-splicing on all cDNA constructs tested”.

19 -p.16. “…our work uncovers an important co-transcriptional function of intron removal…”. I do not see any data that address the co-transcriptional nature of the current findings.

Typos

20 -p.3. “nucletodies” should be “nucleotides”.

21 -p.15. “experimentaion” should be “experimentation”.

Reviewer #2: The authors investigate whether the recently reported function of the EJC in suppressing cryptic SS is conserved in fly. They do this by initally performing a reanalysis of previously published EJC component KDs + RNA-seq, finding substantial activation of cryptic SS shared across KDs of the three EJC core proteins. They use RT-PCR to validate a number of these cryptic SS, and then proceed to explore the mechanism of these changes using minigenes for a select few genes. For both 5' and 3' SS they present convincing evidence that the EJC normally blocks recognition of the cryptic SS. They next use similiar minigene experiments to show some proportion of the cryptic events correspond to resplicing, and point out that this is potentially quite common given the canonical SS motifs (i.e. the frequent GT at the end of the exon and the AG at the beginning). They point out that this is concerning for transgene experiments where the processed sequence is introduced since this will not have the benefit of the EJC protecting it from resplicing.

The paper is well written, motivated and clear. It would be helpful to label the exon/intron numbers in all figures to make them easier to connect to the text.

No discussion is given to the strength of the branchpoint sequence for the regenerated introns. It is surprising that such weak (e.g. 0 NNSPLICE scoring) 3' SS are splice-component: is this being compensated by strong BP? If not, what is the authors' explanation for the splicing of such weak SS?

Minor: I'm confused about the statement that "spurious exonic 3' SS. These represent a majority...". From fig 1 it looks like exonic 5' SS are the biggest category?

Overall this is a nice piece of work with sensible bioinformatic analysis, convincing experiments, and important findings for both splicing biology and functional genetics more broadly.

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #1: Yes

Reviewer #2: None

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Decision Letter 1

John M Greally, Teresa Bowman

8 Apr 2021

Dear Dr Lai,

Thank you very much for submitting your Research Article entitled 'The Exon Junction Complex and intron removal prevent re-splicing of mRNA' to PLOS Genetics.

The manuscript was fully evaluated at the editorial level and by independent peer reviewers. The reviewers appreciated the attention to an important topic but identified some concerns that we ask you address in a revised manuscript. The comments are mostly to improve the description in the text and in the figures as to the identity of the tested amplicons. This point is important to address to ensure the ability of future interested scientists to reproduce the work. 

We therefore ask you to modify the manuscript according to the review recommendations. Your revisions should address the specific points made by reviewer #1. The revised work can be assessed at the editorial level to help expedite a final decision. 

In addition we ask that you:

1) Provide a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript.

2) Upload a Striking Image with a corresponding caption to accompany your manuscript if one is available (either a new image or an existing one from within your manuscript). If this image is judged to be suitable, it may be featured on our website. Images should ideally be high resolution, eye-catching, single panel square images. For examples, please browse our archive. If your image is from someone other than yourself, please ensure that the artist has read and agreed to the terms and conditions of the Creative Commons Attribution License. Note: we cannot publish copyrighted images.

We hope to receive your revised manuscript within the next 30 days. If you anticipate any delay in its return, we would ask you to let us know the expected resubmission date by email to plosgenetics@plos.org.

If present, accompanying reviewer attachments should be included with this email; please notify the journal office if any appear to be missing. They will also be available for download from the link below. You can use this link to log into the system when you are ready to submit a revised version, having first consulted our Submission Checklist.

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Please be aware that our data availability policy requires that all numerical data underlying graphs or summary statistics are included with the submission, and you will need to provide this upon resubmission if not already present. In addition, we do not permit the inclusion of phrases such as "data not shown" or "unpublished results" in manuscripts. All points should be backed up by data provided with the submission.

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

PLOS has incorporated Similarity Check, powered by iThenticate, into its journal-wide submission system in order to screen submitted content for originality before publication. Each PLOS journal undertakes screening on a proportion of submitted articles. You will be contacted if needed following the screening process.

To resubmit, you will need to go to the link below and 'Revise Submission' in the 'Submissions Needing Revision' folder.

[LINK]

Please let us know if you have any questions while making these revisions.

Yours sincerely,

Teresa Bowman

Guest Editor

PLOS Genetics

John Greally

Section Editor: Epigenetics

PLOS Genetics

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: Overall, this version is much improved. In particular, the introduction is much more clear, coherent, and complete. The results also are better described and the language more clear. However, a few aspects still need clarification.

1. Figure 1. I appreciate the improved clarity of the model and the addition of the size markers in 1C. However, as far as I can see there are still no indicators as to what the amplicons in the gels are. For example, icons depicting the amplicons like those used in Figure 4D and F would be helpful – except please include an indication of what exons are represented.

2. This also relates to Question 5, which was “what exactly are the amplicons?” The authors say that they confirmed amplicons by Sanger sequencing or by size, and I’m mostly ok with that (although they do not tell us which amplicons were confirmed by sequencing), but they don’t tell us what the amplicons actually are. Without information as to the identity of the amplicons, this work could never be replicated.

3. In Figure 4F, the amplicon icons on the right seem too high, i.e. they aren’t aligned with the gel bands.

4. Question 19. The authors say that they re-worded their statement about “...our work uncovers an important co-transcriptional function of intron removal...”. I maintain that their work does not address the co-transcriptionality of the current findings – and the authors say that they agree. However, on page 19 in the last sentence of the Discussion, they still say “our work uncovers an important co-transcriptional function of intron removal”.

5. Figure 5 C. Again, it would really help the reader to have explicit schematic or icon next to the gels that show what the amplicons are. It is also unclear why the bands using the transgenic vs genetic specific are so different in size.

6. On p. 34, Figure 5 Legend is labeled incorrectly. There are 2 legends labeled "Figure 4".

Reviewer #2: I was already positive about this manuscript and the authors have improved it on revision. I appreciate them also having taken the time to look into whether BP sequence might account for some of the variation they see. The other reviewer was more critical so I will leave it to them to determine whether their concerns are addressed - it certainly appears the authors have made substantial efforts to do so.

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #1: None

Reviewer #2: None

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Decision Letter 2

John M Greally, Teresa Bowman

26 Apr 2021

Dear Dr Lai,

We are pleased to inform you that your manuscript entitled "The Exon Junction Complex and intron removal prevent re-splicing of mRNA" has been editorially accepted for publication in PLOS Genetics. Congratulations! Thank you for carefully addressing all reviewers comments. 

Before your submission can be formally accepted and sent to production you will need to complete our formatting changes, which you will receive in a follow up email. Please be aware that it may take several days for you to receive this email; during this time no action is required by you. Please note: the accept date on your published article will reflect the date of this provisional acceptance, but your manuscript will not be scheduled for publication until the required changes have been made.

Once your paper is formally accepted, an uncorrected proof of your manuscript will be published online ahead of the final version, unless you’ve already opted out via the online submission form. If, for any reason, you do not want an earlier version of your manuscript published online or are unsure if you have already indicated as such, please let the journal staff know immediately at plosgenetics@plos.org.

In the meantime, please log into Editorial Manager at https://www.editorialmanager.com/pgenetics/, click the "Update My Information" link at the top of the page, and update your user information to ensure an efficient production and billing process. Note that PLOS requires an ORCID iD for all corresponding authors. Therefore, please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field.  This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager.

If you have a press-related query, or would like to know about making your underlying data available (as you will be aware, this is required for publication), please see the end of this email. If your institution or institutions have a press office, please notify them about your upcoming article at this point, to enable them to help maximise its impact. Inform journal staff as soon as possible if you are preparing a press release for your article and need a publication date.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Genetics!

Yours sincerely,

Teresa Bowman

Guest Editor

PLOS Genetics

John Greally

Section Editor: Epigenetics

PLOS Genetics

www.plosgenetics.org

Twitter: @PLOSGenetics

----------------------------------------------------

Comments from the reviewers (if applicable):

----------------------------------------------------

Data Deposition

If you have submitted a Research Article or Front Matter that has associated data that are not suitable for deposition in a subject-specific public repository (such as GenBank or ArrayExpress), one way to make that data available is to deposit it in the Dryad Digital Repository. As you may recall, we ask all authors to agree to make data available; this is one way to achieve that. A full list of recommended repositories can be found on our website.

The following link will take you to the Dryad record for your article, so you won't have to re‐enter its bibliographic information, and can upload your files directly: 

http://datadryad.org/submit?journalID=pgenetics&manu=PGENETICS-D-20-01536R2

More information about depositing data in Dryad is available at http://www.datadryad.org/depositing. If you experience any difficulties in submitting your data, please contact help@datadryad.org for support.

Additionally, please be aware that our data availability policy requires that all numerical data underlying display items are included with the submission, and you will need to provide this before we can formally accept your manuscript, if not already present.

----------------------------------------------------

Press Queries

If you or your institution will be preparing press materials for this manuscript, or if you need to know your paper's publication date for media purposes, please inform the journal staff as soon as possible so that your submission can be scheduled accordingly. Your manuscript will remain under a strict press embargo until the publication date and time. This means an early version of your manuscript will not be published ahead of your final version. PLOS Genetics may also choose to issue a press release for your article. If there's anything the journal should know or you'd like more information, please get in touch via plosgenetics@plos.org.

Acceptance letter

John M Greally, Teresa Bowman

21 May 2021

PGENETICS-D-20-01536R2

The Exon Junction Complex and intron removal prevent re-splicing of mRNA

Dear Dr Lai,

We are pleased to inform you that your manuscript entitled "The Exon Junction Complex and intron removal prevent re-splicing of mRNA" has been formally accepted for publication in PLOS Genetics! Your manuscript is now with our production department and you will be notified of the publication date in due course.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript.

Soon after your final files are uploaded, unless you have opted out or your manuscript is a front-matter piece, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting PLOS Genetics and open-access publishing. We are looking forward to publishing your work!

With kind regards,

Katalin Szabo

PLOS Genetics

On behalf of:

The PLOS Genetics Team

Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom

plosgenetics@plos.org | +44 (0) 1223-442823

plosgenetics.org | Twitter: @PLOSGenetics

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Core-EJC depletion yields broad activation of de novo splice junctions.

    (A) Strong overlap of de novo splice junctions between core-EJC knockdown conditions. The Venn diagram depicts which of 1677 junctions with at least 5 split reads had > 2-fold split read changes between treatment and controls. p-value for three-way overlap was calculated using a permutation test with 10^8 tests. (B) Strong overlap of high-confidence de novo splice junctions between core-EJC knockdown conditions. The Venn diagram depicts which of 876 junctions with at least 5 split reads and > 2-fold split read changes also show > 2-fold changes in percent selected index (PSI) between treatment and controls. p-value for three-way overlap was calculated using a permutation test with 10^8 tests. (C) Knockdown of EJC factors in S2 cells using dsRNA. quantitative rt-PCR of core-EJC and btz transcripts after dsRNA treatment. (D) Sashimi plot illustrating the expression of annotated alternative isoforms for unkempt (unk) in S2 cells. The location of rtPCR primers and alternative isoforms are included.

    (TIF)

    S2 Fig. Locations of rtPCR primers within target transcripts.

    Gene models for genes tested in Fig 1C and primers are illustrated from the UCSC genome browser. Mapping of products obtained from spurious splicing indicate transcript changes.

    (TIF)

    S3 Fig. A majority of cryptic 3’ SS activated under EJC-loss are weak.

    (A) Nucleotide content of cryptic 3’ SS. These sequences, apart from the invariant AG dinucleotide show poor strength. (B) BP motif obtained by analysis of 10000 annotated introns. (C) Plot indicating the relationship between BP motif and spurious 3’ SS strength. (D) Example of a weak cryptic 3’ SS (NNSPLICE score of 0.29) found on the CG7408 transcript. Sashimi plot indicating splice junction counts in EJC LOF and control datasets. The locations of annotated and spurious 3’ SS are shown. Conservation of the weak splice site is depicted using the multiple alignment format on the UCSC genome browser, as well as phyloP and phastCons scores. The location of spacer sequences schematized in Fig 2D is marked.

    (TIF)

    S4 Fig. Evidence for out-of-order intron removal in unkempt and CkIIβ.

    (A) Evidence for out-of-order intron removal for unkempt. Top: Sashimi plot indicating the expression of annotated and spurious splicing using control and mago knockdown RNA sequencing datasets. The location of the spurious 3’ SS relative to the wildtype transcript isoforms is marked. Below: nano-COP reads mapping to the portion of unkempt that undergoes spurious splicing. Within the reads, boxes represent coverage and lines represent skipped coverage due to splicing. Note that skipped read coverage maps to the location of annotated introns. Reads that indicate out-of-order processing are marked–here the downstream intron is removed, but an upstream intron (according to the annotated models) is not processed. Within this locus, there were no examples of reads with all introns removed. (B) Evidence for out-of-order intron removal for CkIIβ. As in (A), the top shows a sashimi plot whereas the bottom represents nano-COP reads. For this locus, there was evidence for fully spliced, fully unspliced and partially spliced products. We identified two instances of out-of-order intron removal and one instance of ordered intron removal.

    (TIF)

    S5 Fig. A majority of cryptic 5’ SS activated under EJC-loss are weak.

    (A) Nucleotide content of cryptic 5’ SS. (B) Schematic of a de novo splicing event detected on the CG3632 transcript. Validation of splicing defects shown on the right. (C) Cryptic 5’ SS (NNSPLICE score of 0.54) found on the CG3632 transcript. Conservation of the weak splice site is depicted using the multiple alignment format on the UCSC genome browser, as well as phyloP and phastCons scores.

    (TIF)

    S6 Fig. de novo splicing on CkIIβ is a result of dual cryptic splice site activation.

    (A) Sashimi plot depicting HISAT2-mapped sequencing coverage along a portion of CkIIβ, which has a cryptic 3’ SS that is activated under core-EJC LOF. Junction spanning read counts mapping to the canonical junction are circled, whereas cryptic junction read counts are squared. Note that spliced reads mapping to the cryptic junction are found in eIF4AIII, mago and tsu but not the control comparison. (B) Schematic of a de novo splicing event detected on the CkIIβ transcript. (C) Validation of CkIIβ cryptic 3’ SS activation in core-EJC, but not btz or lacZ KD conditions. (D) Models that explain the CkIIβ splicing defects. Path 1 and 2 reflect alternate orders of intron removal. Crucially, path 1 leads to EJC-suppressed cryptic splicing on mRNAs using the indicated 5’ recursive splice site and a cryptic 3’ SS, whereas path 2 can also produce a splice defect after removal of intron 2.

    (TIF)

    S7 Fig. de novo splicing on CG31156 is a result of dual cryptic splice site activation.

    (A) Sashimi plot depicting HISAT2-mapped sequencing coverage along a portion of CG31156, which has a cryptic 5’ SS that is activated under core-EJC LOF. Junction spanning read counts mapping to the canonical junction are circled, whereas cryptic junction read counts are squared. Note that spliced reads mapping to the cryptic junction are found in eIF4AIII, mago and tsu but not the control comparison. (B) Schematic of a de novo splicing event detected on the CG31156 transcript. (C) Conservation of the cryptic 5’ SS (NNSPLICE score of 0.54) and a potential 3’ recursive splice site (NNSPLICE score of 0.98) found on the CG31156 transcript highlighted in green, relative to the gene model. Conservation of the splice site is depicted using the multiple alignment format on the UCSC genome browser, as well as phyloP scores. Canonical splice sites are highlighted in yellow. (D) Model of activation of dual cryptic splice sites on the CG31156 transcript. Activation of the cryptic 5’ SS with an additional cryptic 3’ recursive splice sites leads to deletion of 110 nt of mRNA.

    (TIF)

    S8 Fig. Re-splicing on mRNAs alters translated proteins.

    (A-C) Protein and transcript structures are schematized and the location of cryptic resplicing highlighted in blue. (A) Re-splicing on baboon leads to a 54 nt deletion of the mRNA and an 18 amino acid deletion. The deletion does not overlap known domains. Conservation plots for deleted 54 nt region is included. (B) Re-splicing on eIF4G1 leads to a 131 nt deletion, leading to a change in reading frame and truncation of the C terminal domains of eIF4G1. Importantly, critical domains required for eIF4G1 function are lost due to re-splicing. (C) Re-splicing on straw leads to a 91 nt deletion, leading to a change in reading frame and truncation of the protein. Importantly, 2 of 3 Plastocyanin-like domains are lost due to transcript defects.

    (TIF)

    S1 Table. Drosophila cryptic splice junctions that are repressed by the Exon Junction Complex (EJC).

    This table provides the genomic locations, host genes, and classification of de novo unannotated splice junctions discovered in EJC-knockdown data from S2 cells.

    (XLSX)

    S2 Table. Gene ontology (GO) analysis of genes with cryptic splicing that is repressed by the EJC.

    (XLSX)

    S3 Table. Oligonucleotide sequences used in this study.

    The tabs summarize primers used to clone constructs, to knockdown gene products, and to assess mRNA processing.

    (XLSX)

    Attachment

    Submitted filename: 2021_0225_PlosGen_EJC_ref_responses.pdf

    Attachment

    Submitted filename: 2021_0410_EJC_PlosGen_2ndreviews for submit.pdf

    Data Availability Statement

    All custom scripts used in this study are reported on the Lai lab GitHub page (https://github.com/Lai-Lab-Sloan-Kettering).


    Articles from PLoS Genetics are provided here courtesy of PLOS

    RESOURCES